Kolexia
Bourdin Arnaud Pneumologie
Bourdin Arnaud
Pneumologie
Hôpital Arnaud de Villeneuve
Limoges, France
552 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Asthme Broncho-pneumopathie chronique obstructive Maladies pulmonaires Hypertension artérielle Bronchopneumopathies obstructives Fibrose Fibrose pulmonaire Inflammation Hypertension artérielle pulmonaire

Collaborateurs

Voir plus
Chanez Pascal
Chanez Pascal
Hôpital Nord Marseille, Marseille, France
Charriot Jeremy
Charriot Jeremy
Hôpital Arnaud de Villeneuve, Limoges, France
Gamez Dubuis Anne Sophie
Gamez Dubuis Anne Sophie
Hôpital Arnaud de Villeneuve, Limoges, France
Taille Camille
Taille Camille
Hôpital Bichat-Claude-Bernard, Paris, France

Industries

Voir plus
AstraZeneca
78 collaboration(s)
Dernière en 2023
Sanofi
61 collaboration(s)
Dernière en 2023
GSK
53 collaboration(s)
Dernière en 2023
Novartis
28 collaboration(s)
Dernière en 2022

Dernières activités

Voir plus
IMPAHCT-FUL: A Long-Term Extension, Multi-Center Safety Study of AV-101 in Subjects With Pulmonary Arterial Hypertension (PAH) Who Have Completed Study AV-101-002 (IMPAHCT-FUL)
Essai Clinique (Aerovate Therapeutics)   13 mars 2024
IMPAHCT: A Phase 2b/3, Randomized, Double-Blind, Placebo-Controlled, 24-Week Dose Ranging and Confirmatory Study to Evaluate the Safety and Efficacy of AV-101 in Patients With Pulmonary Arterial Hypertension (PAH)
Essai Clinique (Aerovate Therapeutics)   11 mars 2024
Modeling T2 high severe asthma using human induced pluripotent stem cells (hiPSC).
Revue des maladies respiratoires   08 mars 2024
REVERT: REVErsing Airway Remodelling With Tezepelumab : a Protocol for a Double-blind Randomized Controlled Trial for Patients With Asthma
Essai Clinique (CHU Montpellier)   27 février 2024
Benralizumab versus Mepolizumab for Eosinophilic Granulomatosis with Polyangiitis.
The New England journal of medicine   23 février 2024
CT Imaging Assessment of Response to Treatment in Allergic Bronchopulmonary Aspergillosis in Adults With Bronchial Asthma.
Chest   20 février 2024
Reply to "Exploring the long-term effects of biologic initiation in severe asthma: Insights from the International Severe Asthma Registry".
The journal of allergy and clinical immunology. In practice   14 février 2024
Similarities and differences of interstitial lung disease associated with pathogenic variants in SFTPC and ABCA3 in adults.
Respirology (Carlton, Vic.)   12 février 2024
Longitudinal patterns of intermittent oral corticosteroid use for asthma in the UK
The journal of allergy and clinical immunology. Global   02 février 2024
Evaluating the Effect of Dupilumab on Type 2 Airway Inflammation and Mucus Plugging in Patients with Uncontrolled Moderate-To-Severe Asthma: the VESTIGE Trial
Programs and Abstracts of Papers to be Presented During Scientific Sessions: 2024 AAAAI Annual Meeting   01 février 2024